docetaxel,darolutamide
bayer
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'arasens']
really helpful subgroup data from arasens on how patients with high vs low risk/volume disease benefit from triplet therapy. builds on last year s impressive initial results. will help guide selection of therapy for pts with mhspc. #gu23 
Medical Oncologist & Cancer Care Delivery Researcher @MGHCancerCenter. @MGHMedicine, @Harvardmed & @Rhodes_Trust alum